Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

The greater number of patients seeking prescriptions for influenza antiviral drugs or antibiotics to treat secondary infections, as well as advice on OTC influenza products, will likely affect pharmacies, according to CDC.

   

Related Articles

Mylan Receives FDA Approval for Generic Version of Prevacid Through its Subsidiary Matrix Laboratories
Mylan, 11/11/09    Relevance Score: 70%

Teva Receives Final Approval For Generic Prevacid Delayed-Release Capsules
Teva Pharmaceutical Industries, 11/11/09    Relevance Score: 70%

Covidien Receives FDA Approval for Oral Transmucosal Fentanyl Citrate Product
Covidien, 11/05/09    Relevance Score: 70%

Ultimate Fate of Oncology Drugs Approved by the US Food and Drug Administration Without a Randomized Trial
Journal of Clinical Oncology, 10/16/09    Relevance Score: 70%

Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment SinemetÂ
Mylan, 10/01/09    Relevance Score: 70%

Today in Over The Counter (OTC)...keeping you current

Two cases of wheat-dependent anaphylaxis induced by aspirin administration but not by exercise
Clinical and Experimental Dermatology, 11/25/09

Clinical Features of Gastroduodenal Ulcer in Japanese Patients Taking Low-Dose Aspirin
Digestive Diseases and Sciences, 11/25/09

Addition of cilostazol reduces biological aspirin resistance in aspirin users with ischaemic stroke: a double-blind randomized clinical trial
European Journal of Neurology, 11/23/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address